Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2020.3.59

Markevich D.P.1, Marochkov A.V.2, Livinskaya V.A.3
Anesthesiologic management and intensive care of traumatic brain injury and C-reactive protein as a criterion of survival and treatment efficacy of patients
1Mogilev Emergency City Hospital, Mogilev, Republic of Belarus
2Mogilev Regional Hospital, Mogilev, Republic of Belarus
3Belarusian-Russian University, Mogilev, Republic of Belarus

Vestnik VGMU. 2020;19(3):59-68.

Abstract.
Objectives. To determine the changes in the level of serum C-reactive protein (CRP) in the blood serum and the possibility of its use as a criterion to predict the severity and outcome of patients’ treatment with traumatic brain injury (TBI).
Material and methods. CRP was made in 48 operated patients with TBI. Patients were different with respect to the severity of their condition and treatment outcomes. CRP was determined at 7 stages of the study: stage I – until 1-2 hours before surgery, then after surgery: stage II – in 11 (6; 17) hours, stage III – in 35 (29; 40) hours, stage IV – in 60 (52; 65) hours, stage V – in 108 (100; 113) hours, stage VI – in 155 (148; 161) hours, stage VII – after 226 (220; 233) hours.
Results. Significant differences in CRP between groups of patients with severe and moderate TBI were revealed at stages V – VII. At the 5th stage, in patients with severe TBI CRP was 108.8 (103.4; 187.6) mg/l, with a moderate head injury – 38.8 (27.2; 78.5) mg/l, p=0.001. At stage VI, in patients with severe head injury, CRP was 104.8 (90.8; 174.5) mg/l, with a moderate head injury – 10.5 (3.8; 25.9) mg/l, p=0.002. At stage VII, in patients with severe TBI, CRP was 107.1 (83.4; 144.6) mg/l, with a moderate TBI – 11.0 (5.5; 84.5) mg/l, p=0.008. The sensitivity of CRP at stage VII for an unfavorable outcome was 69%, specificity – 80%.
Conclusions. The highest level of CRP in patients with head injury was noted in 60 (52; 65) hours after craniotomy – 110 (90.7;171) mg/l. Significant differences of serum CRP between patients with severe and moderate TBI were revealed on the 5th, 7th and 10th day after surgery. The level of CRP in 108 (100; 113) hours after surgery has a prognostic ability to develop an unfavorable TBI outcome.
Key words: C-reactive protein, traumatic brain injury, anesthesia, neuroanesthesiology.

Financing. To conduct the study the grant sources of the President of the Republic of Belarus were used.

References

1. Vel'kov VV. C-reactive protein in the laboratory diagnosis of acute inflammation and in assessing the risks of vascular pathologies. Kliniko-Lab Konsilium. 2008;(2):37-48. (In Russ.)
2. Belatar B, Laidi F, El Abidi A, Eljaoudi R, Mamouch F, Kabbaj S, et al. Serum levels of selenium and C-reactive protein in comatosepatients with severe traumatic brain injury during the first week ofhospitalization: case-control study. Pan Afr Med J. 2018 Jan;29:36. doi: http://dx.doi.org/10.11604/pamj.2018.29.36.10945
3. Tochilo SA, Marochkov AV, Livinskaya VA. Screening criteria for multiple organ failure after abdominal surgery (clinical trial). Obshchaia Reanimatologiia. 2019;15(3)6:61-72. (In Russ.)
4. Kolomachenko VI. C-reactive protein level in plasma and drainage blood depends on the method of anaesthesia and post-operative analgesia after hip surgery. Anaesthesiol Intensive Ther. 2018;50(2):117-121. doi: http://dx.doi.org/10.5603/AIT.2018.0018
5. Vyalov DV, Nikiforova NV, Churlyaev YuA. Features of a systemic inflammatory response in traumatic brain injury. Obshchaia Reanimatologiia. 2007;3(5-6):29-32. (In Russ.)
6. Giannoudis PV, Smith MR, Evans R, Bellamy MC, Guillou PJ. Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand. 1998 Apr;69(2):184-8. doi: http://dx.doi.org/10.3109/17453679809117625
7. Moharari RS, Zade SA, Etezadi F, Najafi A, Khajavi MR, Bidabadi MS, et al. Impact of subcutaneous infiltration of 0.5% bupivacaine on postoperative C-reactive protein serum titer after craniotomy surgery. Med J Islam Repub Iran. 2013 Feb;27(1):1-6.
8. Bomba G, Maliawan S, Mahadewa T. High serum C-reactive protein as predictor of systemic inflammatory respones syndrome in severe head injury patients. Bali Med J. 2013;2(1):38-41. doi: http://dx.doi.org/10.15562 / bmj.v2i1.37.1
9. Sharma R, Rosenberg A, Bennett ER, Laskowitz DT, Acheson SK. A blood-based biomarker panel to risk-stratify mild traumatic brain injury. PLoS One. 2017 Mar;12(3):e0173798. doi: http://dx.doi.org/10.1371/journal.pone.0173798
10. Su S-H, Xu W, Li M, Zhang L, Wu Y-F, Yu F, et al. Elevated C-eactive protein levels may be a predictor of persistent unfavourable symptoms in patients with mild traumatic brain injury: а preliminary study. Brain Behav Immun. 2014 May;38:111-7. doi: http://dx.doi.org/10.1016/j.bbi.2014.01.009
11. Sun R-Q, Shi X-Y, Yang H-F, Hao Q-M, Zhu L-C, Liu Q-L, et al. An investigation on correlation of severity of brain injury with the expression of activin A and C-reactive protein. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Nov;25(11):681-5. doi: http://dx.doi.org/10.3760/cma.j.issn.2095-4352.2013.11.011
12. Tsentsiper LM, Dryagina NV, Rumyantseva MV, Aybazova MI, Nazarov RV, Ulitin AYu, i dr. Neurohumoral response in the acute period of severe traumatic brain injury. Anesteziologiia Reanimatologiia. 2017;62(3):205-9. (In Russ.)
13. Epifantseva NN, Borshchikova TI, Churlyaev YuA, Dantsiger DG, Nikiforova NV, Kheringson LG. Endogenous intoxication in pulmonary complications in patients with severe traumatic brain injury. Obshchaia Reanimatologiia. 2008;4(3):36-43. (In Russ.)
14. Papangelou A, Radzik BR, Smith T, Gottschalk A. A review of scalp blockade for cranial surgery. J Clin Anesth. 2013 Mar;25(2):150-9. doi: http://dx.doi.org/10.1016/j.jclinane.2012.06.024
15. Sogut O, Guloglu C, Orak M, Sayhan MB, Gokdemir MT, Ustundag M, et al. Trauma scores and neuron-specific enolase, cytokine and c-reactive protein levels as predictors of mortality in patients with blunt head trauma. J Int Med Res. 2010 Sep-Oct;38(5):1708-20. doi: http://dx.doi.org/10.1177/147323001003800516

Information about authors:
Markevich D.P. – head of the anesthesiology and intensive care department, Mogilev Emergency City Hospital,
ORCID: https://orcid.org/0000-0002-1117-3877;
Marochkov A.V. – Doctor of Medical Sciences, professor, anesthesiologist-resuscitator, the anesthesiology & resuscitation department, Mogilev Regional Hospital,
ORCID: https://orcid.org/0000-0001-5092-8315;
Livinskaya V.A. – Candidate of Physical and Mathematical Sciences, associate professor of the Chair «Finance & Accounting», Belarusian-Russian University,
ORCID: https://orcid.org/0000-0001-8953-8533.

Correspondence address: Republic of Belarus, 212030, Mogilev, 2 Botkin str., Mogilev Emergency City Hospital, anesthesiology and intensive care department. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Denis P. Markevich.

Поиск по сайту